We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CHMP Recommends Seven Drugs, Restrictions on Lemtrada and Xeljanz
CHMP Recommends Seven Drugs, Restrictions on Lemtrada and Xeljanz
The EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended five new drugs and two generics for EU approval at its November meeting and called for restrictions on two others.